{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_7zpuUetPPUt","type":"doc","o":"1","documentId":"ucms_7zpuUetPPUt"},"body":{"newStatus":"1","documentId":"ucms_7zpuUetPPUt","staticId":"ucms_7zpuUetPPUt","title":"工信部:研究利用现有资金渠道,推动增加疫苗研发和产业化投入","shareTitle":"工信部:研究利用现有资金渠道,推动增加疫苗研发和产业化投入","thumbnail_doc":"","thumbnail":"","source":"","author":"","editorcode":"weMedia","editTime":"2020-09-17 11:46:00","updateTime":"2020\/09\/17 11:46:00","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/7zpuUetPPUt","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/7zpuUetPPUt","commentsUrl":"ucms_7zpuUetPPUt","commentCount":0,"text":"
证券时报e公司讯,工信部披露对十三届全国人大三次会议第6707号建议的答复:研究利用现有资金渠道,推动增加疫苗研发和产业化投入,支持企业加强核心技术攻关,提升产业创新水平,积极推动扩大疫苗产能,提高疫苗生产技术和质量水平。统筹整合现行医药储备资源,科学调整储备的品类、规模、结构,健全完善国家公共卫生储备专项,研究将疫苗纳入储备范围,实行国家和省级两级储备,提升疫苗供应保障能力。<\/p>","img":[],"summary":"证券时报e公司讯,工信部披露对十三届全国人大三次会议第6707号建议的答复:研究利用现有资金渠道,推动增加疫苗研发和产业化投入,支持企业加强核心技术攻关,提升产","sharesummary":"证券时报e公司讯,工信部披露对十三届全国人大三次会议第6707号建议的答复:研究利用现有资金渠道,推动增加疫苗研发和产业化投入,支持企业加强核心技术攻关,提升产","commentType":"0","wemediaEAccountId":"706","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002KD4Lff-_Edss8--hpyg7OvRyG4w85zXrKe9VKs72ZCewU__","praise":"0","like_num":"0"}}